BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11907106)

  • 1. The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US)2, US3, US6, and US11 gene products.
    Park B; Oh H; Lee S; Song Y; Shin J; Sung YC; Hwang SY; Ahn K
    J Immunol; 2002 Apr; 168(7):3464-9. PubMed ID: 11907106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytomegalovirus UL18 utilizes US6 for evading the NK and T-cell responses.
    Kim Y; Park B; Cho S; Shin J; Cho K; Jun Y; Ahn K
    PLoS Pathog; 2008 Aug; 4(8):e1000123. PubMed ID: 18688275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules.
    Jun Y; Kim E; Jin M; Sung HC; Han H; Geraghty DE; Ahn K
    J Immunol; 2000 Jan; 164(2):805-11. PubMed ID: 10623826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation.
    Barel MT; Ressing M; Pizzato N; van Leeuwen D; Le Bouteiller P; Lenfant F; Wiertz EJ
    J Immunol; 2003 Dec; 171(12):6757-65. PubMed ID: 14662880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A short isoform of human cytomegalovirus US3 functions as a dominant negative inhibitor of the full-length form.
    Shin J; Park B; Lee S; Kim Y; Biegalke BJ; Kang S; Ahn K
    J Virol; 2006 Jun; 80(11):5397-404. PubMed ID: 16699020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11.
    Pande NT; Powers C; Ahn K; Früh K
    J Virol; 2005 May; 79(9):5786-98. PubMed ID: 15827193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.
    Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
    J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation.
    Falk CS; Mach M; Schendel DJ; Weiss EH; Hilgert I; Hahn G
    J Immunol; 2002 Sep; 169(6):3257-66. PubMed ID: 12218145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation.
    Barel MT; Pizzato N; Le Bouteiller P; Wiertz EJ; Lenfant F
    Int Immunol; 2006 Jan; 18(1):173-82. PubMed ID: 16361314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytomegalovirus US3 modulates destruction of MHC class I molecules.
    Noriega VM; Hesse J; Gardner TJ; Besold K; Plachter B; Tortorella D
    Mol Immunol; 2012 Jun; 51(2):245-53. PubMed ID: 22497807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.
    Johnson DC; Hegde NR
    Curr Top Microbiol Immunol; 2002; 269():101-15. PubMed ID: 12224504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of human cytomegalovirus on expression of MHC class I-related chains A.
    Zou Y; Bresnahan W; Taylor RT; Stastny P
    J Immunol; 2005 Mar; 174(5):3098-104. PubMed ID: 15728525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP.
    Ahn K; Gruhler A; Galocha B; Jones TR; Wiertz EJ; Ploegh HL; Peterson PA; Yang Y; Früh K
    Immunity; 1997 May; 6(5):613-21. PubMed ID: 9175839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells.
    Rehm A; Engelsberg A; Tortorella D; Körner IJ; Lehmann I; Ploegh HL; Höpken UE
    J Virol; 2002 May; 76(10):5043-50. PubMed ID: 11967320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytomegalovirus US3 chimeras containing US2 cytosolic residues acquire major histocompatibility class I and II protein degradation properties.
    Chevalier MS; Johnson DC
    J Virol; 2003 Apr; 77(8):4731-8. PubMed ID: 12663780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC class I-subversive gene functions of cytomegalovirus and their regulation by interferons-an intricate balance.
    Benz C; Hengel H
    Virus Genes; 2000; 21(1-2):39-47. PubMed ID: 11022788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process.
    Ahn K; Angulo A; Ghazal P; Peterson PA; Yang Y; Früh K
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10990-5. PubMed ID: 8855296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules.
    Furman MH; Dey N; Tortorella D; Ploegh HL
    J Virol; 2002 Nov; 76(22):11753-6. PubMed ID: 12388737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective suppression of class I major histocompatibility complex expression by the US11 or ICP47 genes can be limited by cell type or interferon-gamma exposure.
    Radosevich TJ; Seregina T; Link CJ
    Hum Gene Ther; 2003 Dec; 14(18):1765-75. PubMed ID: 14670127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental extravillous cytotrophoblasts persistently express class I major histocompatibility complex molecules after human cytomegalovirus infection.
    Terauchi M; Koi H; Hayano C; Toyama-Sorimachi N; Karasuyama H; Yamanashi Y; Aso T; Shirakata M
    J Virol; 2003 Aug; 77(15):8187-95. PubMed ID: 12857887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.